Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Navacaprant hydrochloride by Neumora Therapeutics for Bipolar II Disorder: Likelihood of Approval
Navacaprant hydrochloride is under clinical development by Neumora Therapeutics and currently in Phase II for Bipolar II Disorder. According to...
Data Insights
Navacaprant hydrochloride by Neumora Therapeutics for Bipolar Disorder (Manic Depression): Likelihood of Approval
Navacaprant hydrochloride is under clinical development by Neumora Therapeutics and currently in Phase II for Bipolar Disorder (Manic Depression). According...